Anthem Biosciences
ANTHEM •NSE

Anthem Biosciences

₹888.300.00 (0.00%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events
Livesquawk •
Anthem reported a Q2 standalone net profit of ₹221M, up from ₹198.4M year-on-year.
Livesquawk •
Anthem recorded a BSE block trade valued at Rs 249.9 crore for approximately 3,000,000 shares. The block trade was executed at a price of Rs 833 per share.
Livesquawk •
Jefferies initiates Buy on Anthem Biosciences with ₹1,050 target due to strong CRDMO capabilities. Firm projects ~40% EBITDA margin, ~25% ROCE, and 18–20% earnings CAGR driving growth.